3-Dec-2019
The Conversation
There are two solutions to this impending problem, which most political parties could agree to if they are truly committed to protecting the NHS.
15-Jul-2019
The European Sting
The mutual recognition agreement for inspections of manufacturing sites for human medicines in their respective territories can make it faster and less costly for both sides to bring medicines to the market.
3-Jul-2019
Make Medicines Affordable
Intellectual property barriers, which would hinder access to affordable medicines, have supposedly been removed from the draft RCEP free-trade agreement (FTA).
2-Jul-2019
The Times of India
Three harmful provisions concerning pharmaceuticals and agriculture which were part of the RCEP have been withdrawn.
16-Apr-2019
Project Syndicate
African governments must act immediately to address the AfCFTA’s potential negative implications for Africans’ health.
3-Apr-2019
Council of Canadians
The Parliamentary Budget Officer (PBO) revealed that new intellectual property provisions in the Canada-United States-Mexico Agreement would cost Canadians as much as $169 million more per year for pharmaceutical drugs
22-Jan-2019
Public Citizen
In a letter to Congress, the groups demand that the pact’s giveaways to Big Pharma that would keep medicines unaffordable be removed before the pact is sent to Congress.
14-Jan-2019
Chicago Tribune
NAFTA 2.0 would effectively tie the US Congress’ hands in the struggle against rising drug prices.